```html

Fetal Anomaly – A Comprehensive Medical Guide

Overview

A fetal anomaly (also called a congenital anomaly or birth defect) is any structural or functional abnormality that develops in the fetus during pregnancy. Anomalies can affect any organ system—the heart, brain, limbs, urinary tract, and more—and they range from minor variations that resolve after birth to severe conditions that require surgery or lifelong care.

Who it affects: All pregnant individuals have a chance of having a baby with a fetal anomaly, regardless of age, race, or socioeconomic status. However, certain maternal health conditions, genetic backgrounds, and environmental exposures increase the risk.

Prevalence: According to the CDC, approximately 3 % of live births (about 1 in 33 infants) in the United States are affected by a major congenital anomaly. Globally, the World Health Organization estimates that congenital anomalies account for roughly 7 % of all neonatal deaths (about 2.4 million deaths per year) <sup>[1]</sup>.

Symptoms

Fetal anomalies are often detected before birth through imaging or later after delivery by physical exam or developmental testing. Because the presentation varies with the type of anomaly, the following list groups symptoms by organ system rather than by specific diagnosis.

General / Systemic Signs

• Abnormal growth patterns – fetal size is markedly larger or smaller than gestational age expectations.
• Polyhydramnios or oligohydramnios – too much or too little amniotic fluid, detectable on ultrasound.
• Fetal distress on monitoring – abnormal heart‑rate patterns during routine antenatal testing.

Cardiovascular

• Irregular heart chambers or vessels (e.g., ventricular septal defect, hypoplastic left heart).
• Cardiomegaly (enlarged heart) visible on ultrasound.
• Arrhythmias detected by fetal echocardiography.

Neurological

• Neural tube defects (spina bifida, anencephaly) – absent or malformed spinal cord/brain structures.
• Midline facial clefts or encephalocele.
• Microcephaly (head circumference >2 SD below mean).
• Abnormal brain ventricles (hydrocephalus).

Musculoskeletal

• Limb reduction defects (missing or shortened limbs).
• Clubfoot (talipes equinovarus).
• Skeletal dysplasias (e.g., achondroplasia).

Renal / Urinary

• Prenatal hydronephrosis (dilated renal pelvis).
• Renal agenesis or dysplasia.
• Posterior urethral valves causing bladder obstruction.

Gastrointestinal

• Omphalocele or gastroschisis – intestines protrude through the abdominal wall.
• Duodenal atresia (double‑bubble sign on ultrasound).
• Meconium‑filled intestines seen in utero.

Respiratory

• Congenital diaphragmatic hernia – abdominal organs herniate into the chest cavity.
• Pulmonary hypoplasia (under‑developed lungs).

Genitourinary

• Ambiguous genitalia.
• Turner syndrome (45,X) or other chromosomal anomalies evident on prenatal karyotype.

Causes and Risk Factors

Fetal anomalies arise from a complex interplay of genetic, environmental, and maternal‑health factors.

Genetic Causes

• Chromosomal abnormalities – trisomies (21, 18, 13), Turner syndrome, Klinefelter syndrome.
• Single‑gene mutations – cystic fibrosis (CFTR), spinal muscular atrophy (SMN1), Duchenne muscular dystrophy (DMD).
• Multifactorial inheritance – defects such as cleft lip/palate involve several genes plus environmental triggers.

Environmental Exposures

• Teratogenic medications – isotretinoin, thalidomide, certain antiepileptics (e.g., valproate).
• Infections – rubella, cytomegalovirus, toxoplasmosis, Zika virus.
• Maternal substance use – alcohol (fetal alcohol spectrum disorders), tobacco, illicit drugs.
• Radiation – high‑dose X‑ray or radiation therapy during organogenesis (weeks 2‑8).

Maternal Health Conditions

• Pre‑existing diabetes (especially poorly controlled) increases risk of cardiac and neural tube defects.
• Obesity (BMI ≥ 30) – linked to neural tube and cardiac anomalies.
• Poor nutritional status – notably folate deficiency (neural tube defects).
• Autoimmune diseases (e.g., lupus) with certain auto‑antibodies (anti‑Ro/SSA) that can affect the heart.

Other Risk Factors

• Advanced maternal age (≥35 years) – higher chance of chromosomal anomalies.
• Previous child with a congenital anomaly.
• Consanguineous marriage (first‑cousin relationships) – raises recessive disorder risk.
• Exposure to high‑level environmental pollutants (e.g., pesticides, heavy metals).

Diagnosis

Early detection allows for informed decision‑making, pregnancy management, and perinatal planning.

First‑Trimester Screening (10–14 weeks)

• Combined test – maternal serum PAPP‑A & β‑hCG + nuchal translucency ultrasound; high‑risk results may prompt further testing.
• Non‑invasive prenatal testing (NIPT) – analyzes cell‑free fetal DNA in maternal blood for chromosomal aneuploidies; sensitivity >99 % for trisomy 21.

Second‑Trimester Anatomical Survey (18–22 weeks)

• Detailed ultrasound – evaluates organ structure, growth, and amniotic fluid volume; detects >80 % of major structural anomalies.
• Fetal echocardiography – specialized ultrasound of the heart, indicated when maternal risk factors or abnormal four‑chamber view are present.

Targeted Genetic Testing

• Amniocentesis (15–20 weeks) – obtains amniotic fluid for karyotype, microarray, or gene‑panel testing.
• Chorionic villus sampling (CVS) (10–13 weeks) – earlier tissue sampling for similar analyses.
• Exome/Genome sequencing – increasingly used when ultrasound shows anomalies but standard tests are normal.

Additional Investigations

• Maternal serology for TORCH infections if infection is suspected.
• Maternal glucose tolerance test for undiagnosed diabetes.
• Fetal MRI (after 20 weeks) – superior for central nervous system anomalies.

Treatment Options

Management depends on the specific anomaly, gestational age, and parental wishes. Options range from in‑utero interventions to post‑natal surgery and lifelong care.

In‑Utero (Fetal) Therapies

• Fetal surgery – e.g., repair of spina bifida (myelomeningocele) before 26 weeks improves neurologic outcomes (MOMS trial).
• Balloon atrial septostomy – creates a hole in the heart for certain severe cardiac defects.
• Medication delivery – maternal administration of steroids for lung maturity, or steroids for congenital adrenal hyperplasia.

Medications

• Folic acid supplementation (400–800 µg daily) pre‑conceptionally and during early pregnancy to *prevent* neural tube defects.
• Maternal anti‑seizure drug adjustment – switching from valproate to lamotrigine when feasible.
• Beta‑blockers for certain arrhythmias detected in utero.

Surgical Interventions After Birth

• Cardiac surgery (e.g., repair of tetralogy of Fallot) within the first months of life.
• Neonatal abdominal surgery for gastroschisis, omphalocele, or intestinal atresia.
• Neurosurgical procedures for hydrocephalus (shunt placement) or myelomeningocele repair.
• Orthopedic correction for clubfoot (Ponseti casting) and limb deficiencies.

Supportive & Lifestyle Measures

• Specialized neonatal intensive care unit (NICU) support for preterm or critically ill infants.
• Early intervention services (physical, occupational, speech therapy).
• Genetic counseling for families planning future pregnancies.
• Nutrition optimization—e.g., high‑calorie formulas for infants with cardiac failure.

Living with Fetal Anomaly

Families face emotional, logistical, and medical challenges. The following strategies help improve quality of life.

• Build a multidisciplinary care team – pediatrician, maternal‑fetal medicine specialist, geneticist, surgeon, therapist, and social worker.
• Stay informed – ask for written summaries after appointments and keep a personal health record.
• Connect with support groups – March of Dimes, National Organization for Rare Disorders (NORD), and condition‑specific groups.
• Plan for appointments – keep a calendar of prenatal scans, post‑natal surgeries, and therapy sessions.
• Manage mental health – counseling, mindfulness, or peer‑support can reduce anxiety and depression.
• Financial navigation – work with hospital financial counselors; many insurers cover prenatal testing and NICU care.

Prevention

While not all anomalies are preventable, many strategies reduce risk substantially.

• Folic acid – 400 µg daily for at least one month before conception and through the first 12 weeks (up to 800 µg for higher‑risk women).
• Vaccination – ensure rubella immunity before pregnancy; Zika‑free travel guidance.
• Control chronic conditions – tight glucose control for diabetes, blood pressure management, and thyroid regulation.
• Avoid teratogens – discontinue isotretinoin, limit alcohol, quit smoking, and discuss all medications with a provider.
• Healthy lifestyle – balanced diet, regular moderate exercise, and maintaining a healthy BMI.
• Environmental safety – limit exposure to pesticides, lead, and other industrial chemicals.
• Pre‑conception genetic counseling – especially for couples with a family history of inherited disorders.

Complications

If a fetal anomaly is left untreated, complications can be severe and may affect survival, development, or long‑term health.

• Respiratory failure – diaphragmatic hernia or severe lung hypoplasia can lead to neonatal ventilator dependence.
• Heart failure – uncorrected critical cardiac defects cause poor perfusion and may be fatal within weeks.
• Neurologic impairment – untreated hydrocephalus → increased intracranial pressure, intellectual disability.
• Renal insufficiency – bilateral renal agenesis is incompatible with life; unilateral disease may lead to chronic kidney disease.
• Feeding and growth problems – gastrointestinal atresias can cause malnutrition and failure to thrive.
• Psychosocial impact – families may experience chronic stress, financial strain, and reduced quality of life.

When to Seek Emergency Care

---

References:

1. World Health Organization. Congenital anomalies. 2022.
2. Centers for Disease Control and Prevention. Birth Defects Data and Statistics. 2023.
3. Mayo Clinic. Congenital anomalies. Updated 2024.
4. American College of Obstetricians and Gynecologists (ACOG). Fetal Anomaly Screening. 2020.
5. NIH National Institute of Child Health and Human Development. Congenital Anomalies. 2024.

```